Youngevity International, Inc. reported the completion of the restatement of its previously issued quarterly financial statements for 2019. Now, the company will begin an audit of the fiscal year 2020.
Youngevity International, Inc. has released a report for the company’s financial results in 2019.
Youngevity International, Inc. announced that it has received notice from the Nasdaq Hearings Panel that its company’s securities will be delisted from The Nasdaq Stock Market LLC. This determination was made based upon the company’s non-compliance with the filing requirements set forth in Nasdaq Listing Rule 5250(c)(1) for failing to file its Form 10-K for […]
Youngevity International, Inc. announced changes to its Board of Directors. The company stated that effective February 11, 2020, in order to maintain compliance with the corporate governance requirements of The Nasdaq Capital Market, and specifically Listing Rule 5605(b) which provides that a listed company’s board of directors shall be comprised of a majority of independent directors, Michelle […]
Youngevity International, Inc. announced changes to its Board of Directors. The company stated that effective February 11, 2020, in order to maintain compliance with the corporate governance requirements of The Nasdaq Capital Market, and specifically Listing Rule 5605(b) which provides that a listed company’s board of directors shall be comprised of a majority of independent directors, Michelle […]
Youngevity International, Inc. reported revenue of $34 million for the three months ended September 30, 2019, down 13 percent from Q3 2018. Direct selling revenue down nearly 12% for the quarter “Although we have recently made great strides in producing revenue growth this year, the third quarter posed a number of challenges as we faced seasonally slower sales for […]
Youngevity International, Inc. announced that is has closed the acquisition of BeneYOU, LLC’s assets with an effective date of November 1, 2019. “We are proud to welcome the customers and distributors of Jamberry, Avisae and M.Global into our organization and we look forward to showcasing all of their exciting products to Youngevity distributors and customers […]
Youngevity International, Inc. recently announced the launch of its phytocannabinoid-rich hemp oil product line, HempFX, in Japan. The company disclosed that three products within the HempFX line have gained the appropriate approvals and are now available for purchase in Japan: HempFX Soothe, HempFX Capsules and HempFX Tincture. “HempFX is an ideal representation of our plant-based approach to product development,” […]
The U.S. Direct Selling Association (DSA) recently announced elected officers and directors to the association’s Board of Directors. Officers and directors of the association are recognized leaders who have earned the respect of their colleagues and the public and are committed to lead and direct the affairs of the association. The board officers will each serve one-year […]
Youngevity International, Inc. (NASDAQ: YGYI) announced it is set to join the broad-market Russell 3000® Index at the conclusion of the 2019 Russell indexes annual reconstitution. Annual Russell indexes reconstitution captures the 4,000 largest US stocks as of May 10, ranking them by total market capitalization. Membership in the U.S. all-cap Russell 3000® Index, which […]
Youngevity International, Inc. (NASDAQ: YGYI) reported revenue of $56.3 million for the first quarter ended March 31, 2019, an increase of 30.9 percent over 2018. The company derived approximately 59 percent of its revenue from its direct selling segment and approximately 41 percent of its revenue from its commercial coffee segment. Direct selling segment revenues […]
Youngevity International, Inc. (NASDAQ: YGYI) reported financial results for the fourth quarter and full year ended December 31, 2018. Revenues for the fourth quarter ended December 31, 2018 decreased 12.0 percent to $36,114,000 as compared to $41,041,000 for the fourth quarter ended December 31, 2017. Revenues for the year ended December 31, 2018 decreased 2.0 percent to $162,445,000 as compared to $165,696,000 for the year ended December 31, 2017. “We are […]